| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
275.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 7.4 |
| Insider 3/6 Months : 8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
| Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
| Total People Bought |
0 |
1 |
4 |
8 |
| Total Buy Transactions |
0 |
1 |
6 |
12 |
| Total Shares Sold |
0 |
96,686 |
455,706 |
505,706 |
| Total Sell Value |
$0 |
$136,327 |
$650,097 |
$765,097 |
| Total People Sold |
0 |
1 |
6 |
6 |
| Total Sell Transactions |
0 |
1 |
21 |
22 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Turley James S |
Director |
– • – |
2015-03-12 |
4 |
A |
$47.48 |
$59,967 |
D/D |
1,263 |
4,321 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2015-03-12 |
4 |
A |
$47.48 |
$74,971 |
D/D |
1,579 |
60,672 |
|
- |
|
| Shapiro Robert B |
Director |
– • – |
2015-03-12 |
4 |
A |
$47.48 |
$69,986 |
D/D |
1,474 |
37,883 |
|
- |
|
| Horner Larry D /fa |
Director |
– • – |
2015-03-12 |
4 |
A |
$47.48 |
$69,986 |
D/D |
1,474 |
68,507 |
|
- |
|
| Mitchell Dean J |
Director |
– • • |
2015-03-12 |
4 |
A |
$47.48 |
$69,986 |
D/D |
1,474 |
7,829 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2015-03-12 |
4 |
A |
$47.48 |
$74,971 |
D/D |
1,579 |
37,010 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2015-01-27 |
4 |
B |
$27.00 |
$15,000,012 |
I/I |
555,556 |
5,483,957 |
2.64 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2014-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
344,258 |
58,800 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2014-12-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,679,578) |
0 |
|
- |
|
| Perez Jeffrey Thomas |
SVP, IP AffairsOfficer |
• – – |
2014-08-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,436 |
|
- |
|
| Reed Thomas D. |
Chief Science Officer |
• • – |
2014-05-13 |
4 |
B |
$15.60 |
$9,984 |
I/I |
640 |
2,440 |
2.58 |
- |
|
| Lehr Donald P. |
Chief Legal Officer |
• – – |
2014-05-13 |
4 |
B |
$15.99 |
$29,582 |
D/D |
1,850 |
15,326 |
2.74 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2014-05-13 |
4 |
B |
$15.63 |
$500,457 |
I/I |
32,019 |
829,379 |
2.64 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2014-05-12 |
4 |
B |
$15.89 |
$287,069 |
I/I |
18,066 |
797,360 |
2.64 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2014-05-09 |
4/A |
B |
$13.42 |
$233,239 |
I/I |
17,248 |
129,794 |
2.64 |
- |
|
| Krishnan Suma |
SVP--Product Development |
• – – |
2014-05-09 |
4 |
B |
$14.21 |
$297,022 |
D/D |
20,900 |
20,900 |
2.74 |
- |
|
| Krishnan Krish S |
Chief Operating Officer |
• – – |
2014-05-09 |
4 |
B |
$14.21 |
$297,022 |
D/D |
20,900 |
20,900 |
2.74 |
- |
|
| Huang Kelly |
SVP-Consumer Sector |
• – – |
2014-05-09 |
4 |
B |
$15.78 |
$50,496 |
D/D |
3,200 |
3,200 |
2.74 |
- |
|
| Kasser Thomas R. |
SVP--Food Sector |
• – – |
2014-05-09 |
4 |
B |
$13.39 |
$133,900 |
D/D |
10,000 |
15,000 |
2.74 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2014-05-09 |
4 |
B |
$13.42 |
$202,481 |
I/I |
15,088 |
779,294 |
2.64 |
- |
|
| Turley James S |
Director |
– • – |
2014-04-16 |
4 |
A |
$19.62 |
$59,998 |
D/D |
3,058 |
3,058 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2014-03-27 |
4 |
B |
$25.72 |
$6,249,986 |
I/I |
243,001 |
243,001 |
2.64 |
- |
|
| Mitchell Dean J |
Director |
– • – |
2014-03-20 |
4 |
A |
$30.72 |
$69,980 |
D/D |
2,278 |
6,355 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2014-03-20 |
4 |
A |
$30.72 |
$74,988 |
D/D |
2,441 |
59,093 |
|
- |
|
| Shapiro Robert B |
Director |
– • – |
2014-03-20 |
4 |
A |
$30.72 |
$69,980 |
D/D |
2,278 |
36,409 |
|
- |
|
689 Records found
|
|
Page 25 of 28 |
|
|
0.01 (0.65%) 
